Manufacture of antithymocyte globulin (ATGAM) for clinical trials.

Transplantation, 1979/10;28(4):303-7.

Wechter WJ, Nelson JW, Perper RJ, Parcells AJ, Riebe KW, Evans JS, Satoh PS, Ko H

PMID: 116400

Impact factor: 5.385

Abstract
Methods are described for preparing large amounts of horse anti-human thymocyte globulin (ATG, ATGAM; The Upjohn Company) for clinical use. These methods have been used since 1968 to provide material for clinical trials. Characteristics of 40 lots of ATG are summarized.
MeSH terms
More resources
EndNote: Download